Skip to content
value.today
Athersys logo

Athersys

ATHX
$14 Mlast known market cap, Jul 2023 — no current value
Compare
World rank
—
no current market cap
Revenue
$1 M
annual
value.today research
Net income
$-79 M
-5621.4% margin
value.today research
Employees
83
2019
Wikidata

Athersys in brief

Athersys is a listed company in the Biotechnology industry, based in Cleveland, Ohio, USA. It was founded in 1995. Its last known market value was $14 M (July 2023); there is no current figure. In its latest reported year it had sales of $1 M and a net loss of $79 M. It employs about 83 people. Its shares trade under the symbol ATHX (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Athersys

Athersys is a Clinical Stage Biotechnology company developing novel and proprietary best in class therapies designed to extend and enhance the quality of human life. The company annual revenue is 1.4 million USD and 75 employees as on 2020. The headquarters is in USA.

Athersys timeline

3 events, 1995–2007
  1. 1995
  2. 🏁
    · approximate
    Founded
  3. 2005
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2007
  6. 🔔
    · approximate
    Initial public offering on Nasdaq as ATHX

Events of Athersys from Wikidata and SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$93 M$187 M$280 M$374 M2020202120222023

World rank over time

▼ down 14,598 places since 2020
2020-01-01: #16051#16,05120202021-01-01: #13004#13,00420212022-01-07: #18660#18,66020222022-12-25: #30650#30,65020222023-07-30: #30649#30,6492023

Rank in USA: #3,259 (Jan 2020) · #2,842 (Jan 2021) · #3,815 (Jan 2022) · #5,440 (Dec 2022) · #5,319 (Jul 2023)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
-5621.4%
Operating margin
—
Return on equity
—
Liabilities / assets
—
Revenue per employee
$17 K
Profit per employee
$-948 K

Annual results

Revenue
$1 M
Operating income
—
Net income
$-79 M

How Athersys compares in Biotechnology

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Athersys🇺🇸$14 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jul 30, 2023 (last known)
Employees:
2019
Profile updated:
Nov 15, 2026

Figures from value.today research, Wikidata.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Athersys? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Athersys's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Athersys? Suggest a correction